The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 27, 2022

Filed:

Jan. 24, 2019
Applicants:

Sekisui Medical Co., Ltd., Tokyo, JP;

Hitachi High-technologies Corporation, Tokyo, JP;

Inventors:

Hiroshi Takahashi, Tokyo, JP;

Tadaaki Yoshida, Tokyo, JP;

Yoshimasa Banba, Tokyo, JP;

Yuki Takahashi, Tokyo, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/543 (2006.01); G01N 21/47 (2006.01); G01N 21/31 (2006.01); G01N 21/59 (2006.01); G01N 21/83 (2006.01); G01N 21/17 (2006.01);
U.S. Cl.
CPC ...
G01N 33/54313 (2013.01); G01N 21/31 (2013.01); G01N 21/47 (2013.01); G01N 21/59 (2013.01); G01N 21/83 (2013.01); G01N 2021/1734 (2013.01); G01N 2333/705 (2013.01);
Abstract

The present invention provides a particle enhanced agglutination immunoassay including the steps of: mixing a sample solution containing an analyte with a solution containing insoluble carrier particles carrying a binding partner or binding partners for the analyte to prepare a mixed solution; determining a variation (i) in intensity of light scattered from the mixed solution based on a difference in intensity of scattered light between first and second time points; determining a variation (ii) in absorbance of the mixed solution based on a difference in absorbance between third and fourth time points; and correlating the determined variation (i) in intensity of scattered light and the determined variation (ii) in absorbance with an amount of the analyte present in the sample using a calibration curve plotted based on the variation in intensity of scattered light and a calibration curve plotted based on the variation in absorbance. The present invention employs measurements of the intensity of scattered light and the absorbance in combination for a single assay, and thus provides a particle enhanced agglutination immunoassay which achieves higher sensitivity and a wider dynamic range than conventional assays.


Find Patent Forward Citations

Loading…